Developing antibody discovery and recombination technology towards the goal of modulating cation channels
Open access
Author
Date
2016Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010722799Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH ZürichSubject
KATIONENKANÄLE (MEMBRANBIOLOGIE); IONENKANALMODULATOREN (PHARMAKOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; CATION CHANNELS (MEMBRANE BIOLOGY); ION CHANNEL MODULATORS (PHARMACOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); TARGETED DRUGS (PHARMACOLOGY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)Organisational unit
02070 - Dep. Gesundheitswiss. und Technologie / Dep. of Health Sciences and Technology
Notes
Dissertation. ETH Zürich. 2016. No. 23771.More
Show all metadata
ETH Bibliography
yes
Altmetrics